Volume 25, Number 4—April 2019
Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia
|Outcome||Days since onset||No. specimens with Abs detected/no. tested
||No. patients† with Abs detected/no. tested
|MN||VSV-MERS-S||S ELISA||N ELISA||MN||VSV-MERS-S||S ELISA||N ELISA|
*Abs, antibodies; MERS-CoV, Middle East respiratory syndrome coronavirus; MN, microneutralization assay; N ELISA, nucleocapsid ELISA; S ELISA, spike ELISA; VSV-MERS-S, pseudoparticle neutralization assay; NA, not available.
†Number of patients represents those with available specimens for a given period. Specimens were not available from all patients during all periods. Some specimens were not tested by VSV-MERS-S pseudoparticle assay because of insufficient volume.
1These first authors contributed equally to this article.